Andrew Grigg

15.5k citations
275 papers · 8.9k · 5 hit papers · h-index 48

Impact in

  • Hematology top 0.05%
    • Chronic Myeloid Leukemia Treatments
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
  • Genetics top 0.1%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Chronic Myeloid Leukemia Treatments 53
    • Hematopoietic Stem Cell Transplantation 38
    • Acute Myeloid Leukemia Research 34
    • Chronic Lymphocytic Leukemia Research 64

Andrew Grigg

264 papers receiving 8.7k citations

Andrew Grigg's Hit Papers

Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study 2019 · 253 citations
2530+8+16Years since publication200400600

Peers

Andrew Grigg
Comparison fields: 5 of 113
  • Hematology 4.7k
  • Genetics 3.3k
  • Rheumatology 1.6k
  • Pathology and Forensic Medicine 1.5k
  • Oncology 1.9k
Replace Jiřı́ Mayer with:
Jiřı́ Mayer Czechia
Enrica Morra Italy
Alberto Bosi Italy
Bruno Varet France
Frits van Rhee United States
Fabrizio Pane Italy
Ricardo Pasqüini Brazil
Charles Koller United States
S Tura Italy
Marcos González Spain
Andrew Grigg relative to Jiřı́ Mayer Czechia Jiřı́ Mayer's profile →
Citations per field
00.5×1.5×
Jiřı́ Mayer · 1×
Citations per year

Countries citing papers authored by Andrew Grigg

Since Specialization
Citations

This map shows the geographic impact of Andrew Grigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Grigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Grigg more than expected).

Fields of papers citing papers by Andrew Grigg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Grigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Grigg. The network helps show where Andrew Grigg may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew Grigg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Grigg Line = papers co-authored together Andrew Grigg links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 275 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Hydroxyurea Compared with Anagrelide in High-Risk Essential Thrombocythemia
Hit paper breakdown →
2005613
2
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis
Hit paper breakdown →
2003563
3
High frequency of point mutations clustered within the adenosine triphosphate–binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance
Hit paper breakdown →
2002518
4
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study
Hit paper breakdown →
2013512
5 2008266
6
Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study
Hit paper breakdown →
2019253
7 2002213
8 2010196
9 2002150
10 1997149
11 2014139
12 1999127
13 2003118
14 2007112
15 2016106
16 2003102
17 200599
18 200399
19 201198
20 201596

About Andrew Grigg

Andrew Grigg is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Epidemiology, having authored 275 papers that have together received 8.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (64 papers), Lymphoma Diagnosis and Treatment (63 papers), Chronic Myeloid Leukemia Treatments (53 papers), Hematopoietic Stem Cell Transplantation (38 papers), Acute Myeloid Leukemia Research (34 papers), Eosinophilic Disorders and Syndromes (30 papers), Neutropenia and Cancer Infections (28 papers) and Acute Lymphoblastic Leukemia research (21 papers). The work is most often cited by research in Hematology (4.7k citations), Genetics (3.3k citations), Rheumatology (1.6k citations), Pathology and Forensic Medicine (1.5k citations) and Oncology (1.9k citations). Andrew Grigg has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Jeff Szer, Timothy P. Hughes, Susan Branford, John F. Seymour, Chris Arthur, Kevin Lynch, Zbigniew Rudzki, Kerry Taylor, Richard Herrmann and Anthony P. Schwarer. Their work appears in journals such as Blood, Bone Marrow Transplantation, British Journal of Haematology, Biology of Blood and Marrow Transplantation and Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact